Waters Corporation Reports Strong Q2 2026 Results and Raises Full-Year Guidance

Details

Organic revenue grew 7% as reported and 9% in constant currency, driven by broad-based outperformance across both organic revenue and the acquired businesses. The company reported GAAP EPS of ($1.39) and adjusted EPS of $3.05, landing at the high end of the guidance range. Due to better-than-expected results and broad strengthening in end-market conditions, Waters Corporation raised all components of its full-year 2026 guidance, expecting organic constant currency revenue growth of 7% to 9%, acquired business reported revenue of $3.045 billion, and adjusted EPS of $14.45 to $14.65.

Items reported

About Waters Corporation

Waters Corporation is a leading entity in the field of analytical instruments and software. It primarily focuses on providing laboratory solutions for a variety of sectors, including pharmaceuticals, healthcare, food and beverage, and chemical analysis. The company's offerings include high-performance liquid chromatography, mass spectrometry systems, and various supporting technologies used for advanced research in life sciences. Waters Corporation is pivotal in enhancing laboratory productivity, offering cutting-edge research tools that assist in drug development, quality control, and environmental testing. Operating globally, it serves a wide array of clients, including academic institutions, government agencies, and private industry players. With its commitment to innovation and precision, Waters Corporation plays a crucial role in advancing scientific and technological progress in multiple critical industries worldwide.